Literature DB >> 10356027

Few patients with prostate cancer are willing to be randomised to treatment.

P O'Reilly, L Martin, G Collins.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10356027      PMCID： PMC1115919          DOI： 10.1136/bmj.318.7197.1556a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Patients with prostate cancer should be enrolled in a national, controlled trial.

Authors:  R G Willis
Journal:  BMJ       Date:  1999-01-09
  1 in total
  8 in total

1.  Current prostate cancer treatment: Not what but when?

Authors:  Peter A Massaro; Ilias Cagiannos
Journal:  Can Urol Assoc J       Date:  2016-08       Impact factor: 1.862

2.  Demographic analysis: an update of randomized controlled studies in prostatic oncology.

Authors:  Elias Wehbi; Karen Hersey; Tony Finelli; Neil E Fleshner
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

3.  Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation.

Authors:  Amol K Narang; Carol Gergis; Scott P Robertson; Pei He; Ashwin N Ram; Todd R McNutt; Emily Griffith; Theodore A DeWeese; Stephanie Honig; Harleen Singh; Danny Y Song; Phuoc T Tran; Theodore L DeWeese
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-31       Impact factor: 7.038

Review 4.  Can we deliver randomized trials of focal therapy in prostate cancer?

Authors:  Hashim U Ahmed; Viktor Berge; David Bottomley; William Cross; Rakesh Heer; Richard Kaplan; Tom Leslie; Chris Parker; Clare Relton; Richard Stephens; Matthew R Sydes; Lindsay Turnbull; Jan van der Meulen; Andrew Vickers; Timothy Wilt; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2014-04-22       Impact factor: 66.675

Review 5.  Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult.

Authors:  Jenny Donovan; Nicola Mills; Monica Smith; Lucy Brindle; Ann Jacoby; Tim Peters; Stephen Frankel; David Neal; Freddie Hamdy
Journal:  BMJ       Date:  2002-10-05

Review 6.  Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions.

Authors:  Benjamin A Greenberger; Victor E Chen; Robert B Den
Journal:  Front Oncol       Date:  2019-11-29       Impact factor: 6.244

7.  A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study.

Authors:  L Dickinson; H U Ahmed; A P Kirkham; C Allen; A Freeman; J Barber; R G Hindley; T Leslie; C Ogden; R Persad; M H Winkler; M Emberton
Journal:  Contemp Clin Trials       Date:  2013-06-14       Impact factor: 2.261

8.  Oncologic Outcomes of Radical Prostatectomy and High-Dose Intensity-Modulated Radiotherapy with Androgen-Deprivation Therapy for Relatively Young Patients with Unfavorable Intermediate-Risk Prostate Adenocarcinoma.

Authors:  Szu-Yuan Wu; Shyh-Chyi Chang; Chang-I Chen; Chung-Chien Huang
Journal:  Cancers (Basel)       Date:  2021-03-25       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.